The genotoxic risk in health care workers occupationally exposed to cytotoxic drugs - A comprehensive evaluation by the SCE assay

Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering

Volumn 44, Issue 5, 2009, Pages 462-479

  Kopjar, Nevenka ^a   Kašuba, Vilena ^a   Rožgaj, Ružica ^a   Želježić, Davor ^a   Milić, Mirta ^a   Ramić, Snježana ^b   Pavlica, Vesna ^b   Milković Kraus, Sanja ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Cytotoxic drugs; Genotoxicity; Lymphocytes; Occupational exposure; Sister chromatid exchanges

Indexed keywords

CYTOTOXIC DRUGS; GENOTOXICITY; LYMPHOCYTES; OCCUPATIONAL EXPOSURE; SISTER CHROMATID EXCHANGES;

DAMAGE DETECTION; HEALTH; HEALTH CARE; HEALTH RISKS; HOSPITALS;

OCCUPATIONAL RISKS;

BIOLOGICAL MARKER; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DACARBAZINE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; GEMCITABINE; IDARUBICIN; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; PACLITAXEL; TOPOTECAN; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; BIOLOGICAL MONITORING; CARCINOGENICITY; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CROATIA; DRUG MANUFACTURE; FEMALE; GENOTOXICITY; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL ACCIDENT; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; RISK ASSESSMENT; SISTER CHROMATID EXCHANGE; SMOKING HABIT;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; MUTAGENS; NEOPLASMS; NURSES; OCCUPATIONAL EXPOSURE; SISTER CHROMATID EXCHANGE;

EID: 60849110570     PISSN: 10934529     EISSN: 15324117     Source Type: Journal    
DOI: 10.1080/10934520902719845     Document Type: Article

References (117)

1. Connor, T.H. An evaluation of the permeability of disposable propylene-based protective gowns to a baterry of cancer chemotherapy drugs. Appl. Occup. Environ. Hyg. 1993, 8, 785-789.
2. Valanis, B.; Vollmer, W.M.; Labuhn, K.T.; Glass, A.G. Acute symptoms associated with antineoplastic drug handling among nurses. Cancer Nurs. 1993, 16, 288-295.
3. Connor, T.; McDiarmid, M. Preventing occupational exposures to antineoplastic agents in health care settings. CA Cancer J. Clin. 2006, 56, 354-365.
4. OSHA - Occupational Safety and Health Administration, Office of Occupational Medicine. Guidelines for cytotoxic (antineoplastic) drugs No. 8-1.1.; OSHA Office of Occupational Medicine Publication: Washington DC, 1986.
5. QuapoS 3. Quality standard for the oncology pharmacy service, 4th Ed; Onko-Press: Oldenburg, 2003; 174 pp.
6. National Institute for Occupational Safety and Health. NIOSH alert: preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings; www.cdc.gov/niosh/docs/2004-165 (accessed Dec 2, 2004).
7. American Society of Hospital Pharmacists. ASHP guidelines on handling hazardous drugs. Am. J. Hosp. Pharm. 2006, 63, 1172-1193.
8. Ritchie, M.A.; McAdams, C.; Fritz, N. Exposure risk in the handling and administration of chemotherapy agents: a review and synthesis of the literature. J. Knowledge Synth. Nurs. 1999, 7, 1-10.
9. Turci, R.; Sottani, C.; Spagnoli, G.; Minoia, C. Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analitical methods. J. Chromat. B 2003, 789, 169-209.
10. Spatari, G.; Fenga, C.; Minciullo, P.L.; Di Pasquale, G.; Cacciola, A.; Ventura-Spagnolo, E.; Gangemi, S. Modification of interleukin-15 serum levels in workers exposed to chemotherapeutic agents. Mediat. Inflamm. 2005, 1, 60-62.
11. Laffon, B.; Teixeira, J.P.; Silva, S.; Loureiro, J.; Torres, J.; Pásaro, E.; Méndez, J.; Mayan, O. Genotoxic effects in a population of nurses handling antineoplastic drugs, and relationship with genetic polymorphisms in DNA repair enzymes. Am. J. Ind. Med. 2006, 48, 128-136.
12. Cavallo, D.; Ursini, C.L.; Omodeo-Salè, E.; Iavicoli, S. Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs. Mutat. Res. 2007, 628, 11-18.
13. Cornetta, T.; Padua, L.; Testa, A.; Ievoli, E.; Festa, F.; Tranfo, G.; Baccelliere, L.; Cozzi, R. Molecular biomonitoring of a population of nurses handling antineoplastic drugs. Mutat. Res. 2008, 638, 75-82.
14. Norppa, H.; Sorsa, M.; Vainio, H.; Grohn, P.; Heinonen, E.; Holsti, L.; Nordman, E. Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs. Scand. J. Work Environ. Health. 1980, 6, 299-301.
15. Latt, S.; Allen, J.; Bloom, S.E.; Carrano, A.; Falke, E.; Kram, D.; Schneider, E.; Schreck, R.; Tice, R.; Whitfield, B.; Wollf, S. Sister chromatid exchanges: A report of the Gene-Tox Program. Mutat. Res. 1981, 87, 17-62.
16. Bigatti, P.; Lamberti, L.; Ardito, G.; Armelino, F.; Malanetto, C. Chromosome aberrations and sister chromatid exchanges in occupationally exposed workers. Med. Lav. 1985, 76, 334-339.
17. Mäki-Paakkanen, K. Chromosome aberrations, micronuclei and sister-chromatid exchanges in blood lymphocytes after occupational exposure to low levels of styrene. Mutat. Res. 1987, 189, 399-406.
18. Marez, T.; Shirali, P.; Hildebrand, H.F.; Haguenoer, J.M. Increased frequency of sister chromadid exchange inworkers exposed to high doses of methylmethacrylate. Mutagenesis. 1991, 6, 127-129.
19. Major, J.; Jakab, M.G.; Tompa, A. Genotoxicological investigation of hospital nurses occupationally exposed to ethylene-oxide: I. Chromosome aberrations, sister-chromatid exchanges, cell cycle kinetics, and UV-induced DNA synthesis in peripheral blood lymphocytes. Environ. Mol. Mutagen. 1996, 27, 84-92.
20. Hoerauf, K.H.; Wiesner, G.; Schroegendorfer, K.F.; Jobst, B.P.; Spacek, A.; Harth, M.; Sator-Katzenschlager, G.; Rudiger, H.W. Waste anesthetic gases induce sister chromatid exchanges in lymphocytes of operating room personnel. Brit. J. Anaesth. 1999, 82, 764-766.
21. Gómez-Arroyo, S.; Díaz-Sánchez, Y.; Meneses-Peréz, M.A.; Villalobos-Pietrini, R.; De León- Rodríguez, J. Cytogenetic biomonitoring in a Mexican floriculture worker group exposed to pesticides. Mutat. Res. 2000, 466, 117-124.
22. Joseph, S.; Gadhia, P.K. Sister-chromatid exchange frequency and chromosome aberrations in residents of fluoride endemic regions of south Gujarat. Fluoride 2000, 4, 154-158.
23. Carrere, A.; Andreoli, C.; Galati, R.; Leopardi, P.; Marcon, F.; Rosati, M.V.; Rossi, S.; Tomei, F.; Verdina, A.; Zijno, A.; Crebelli, R. Biomonitoring of exposure to urban air pollutants: analysis of sister chromatid exchanges and DNA lesions in peripheral lymphocytes of traffic policemen. Mutat. Res. 2002, 518, 215-224.
24. Pitarque, M.; Vaglenov, A.; Nosko, M.; Pavlova, S.; Petkova, V.; Hirvonen, A.; Creus, A.; Norppa, H.; Marcos, R. Sister chromatid exchanges and micronuclei in peripheral lymphocytes of shoe factory workers exposed to solvents. Environ. Health Persp. 2002, 110, 399-404.
25. Jayakaran, F.; Thomas, I.M. Sister-chromatid exchanges in anesthesists. Ind. J. Occup. Environ. Med. 2005, 9, 86-89.
26. Rowland, R.E.; Edwards, L.A.; Podd, J.V. Elevated sister chromatid frequencies in New Zealand Vietnam War veterans. Cytogenet. Genome Res. 2007, 116, 248-251.
27. Milic̀, M.; Kašuba, V.; Orešc̀anin, V.; Želježic̀, D.; Kopjar, N.; Rozgaj, R. Chromosome damage in workers in cigarette manufacturing industry. J. Appl. Toxicol. 2008, 28, 399-404.
28. Kang, M.H.; Genser, D.; Elmadfa, I. Increased sister chromatid exchanges in peripheral lymphocytes of patients with Chron's disease. Mutat. Res. 1997, 381, 141-148.
29. Atalay, F.; Baltaci, V.; Alpas, I., Savas, I.; Atikcan, S., Balci, S. Sister chromatid exchange rate from pleural fluid cells in patient with malignant mesothelioma. Mutat. Res. 2000, 465, 159-163.
30. Cortés-Guttiérez, E.I.; Cerda-Flores, R.M.; Leal-Garza, C.H. Sister chromatid exchanges in peripheral lymphocytes from women with carcinoma of the uterine cervix. Cancer Genet. Cytogenet. 2000, 122, 121-123.
31. Cottliar, A.; Fundia, A.; Boerr, L.; Sambuelli, A.; Negreira, S.; Gil, A.; Gomez, J.C.; Chopita, N.; Bernedo, A.; Slavutsky I. High frequencies of telomeric associations, chromosome aberrations, and sister chromatid exchanges in ulcerative colitis. Am. J. Gastroenterol. 2000, 95, 2301-2307.
32. Ivičic̀, N.; Prejac, J.; Kopjar, N.; Momč ilović, B. The sister chromatid exchange rate is inversely related to the Se, Sr, Mn, Cu, and Be trace element nutritional status. J. Trace Elements Med. Biol. 2007, 21(S1), 74-76.
33. Carbonell, E.; Demopoulos, N.A.; Stefanou, G.; Psaraki, K.; Parry, E.M.; Marcos, R. Cytogenetic analysis in peripheral lymphocytes of cancer patients treated with cytostatic drugs: Results from an EC Collaborative Study. Anti-Cancer Drugs 1996, 7, 514-519.
34. Kopjar, N.; Milas, I.; Garaj-Vrhovac, V.; Gamulin, M. Cytogenetic outcomes of adjuvant chemotherapy in non-target cells of breast cancer patients. Hum. Exp. Toxicol. 2007, 26, 1-9.
35. Mourelatos, D. Chromosomes study as predictor of chemoresponse of tumors. Cancer J. 1996, 9, 136-141.
36. Albertini, R.J.; Anderson, D.; Douglas, G.R.; Hagmar, L.; Hemminki, K.; Merlo, F.; Natarajan, A.T.; Norppa, H.; Shuker, D.E.G.; Tice, R.; Waters, M.D.; Aitio A. ICPS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat. Res. 2000, 463, 111-172.
37. Natarajan, A.T. Mechanisms for induction of mutations and chromosome alterations. Environ. Health. Persp. 1993, 101(Suppl 3), 225-229.
38. Beek, B.; Obe, G. Sister chromatid exchanges in human leukocyte chromosomes: spontaneous and induced frequencies in early- and late-proliferating cells in vitro. Hum. Genet. 1979, 49, 51-61.
39. Bonassi, S.; Fontana, V.; Ceppi, M.; Barale, R.; Biggeri, A. Analysis of correlated data in human biomonitoring studies. The case of high sister chromatid exchange frequency cells. Mutat. Res. 1999, 438, 13-21.
40. Carrano, A.V.; Moore, D.H. The rationale and methodology for quantifying sister chromatid exchange in humans. In Mutagenicity: New Horizons in Genetic Toxicology; Heddle, J.A. Ed. Academic Press: New York, 1982, 267-304.
41. Pendzich, J.; Motkykiewicz, G.; Michalska, J.; Wang, L.Y.; Kostowska, A.; Chora̧ży, M. Sister chromatid exchanges and high-frequency cells in men environmentally and occupationally exposed to ambient air pollutants: an intergroup comparison with respect to seasonal changes and smoking habit. Mutat. Res. 1997, 381, 163-170.
42. Ponzanelli, I.; Landi, S.; Bernacchi, F.; Barale, R. The nature of high frequency sister chromatid exchange cells (HFCs). Mutagenesis 1997, 12, 329-333.
43. Perry, P.; Wolff, S. New Giemsa method for the diferrential staining of sister chromatids. Nature 1974, 261, 156-158.
44. Carrano, A.V.; Natarajan, A.T. Considerations for population monitoring using cytogenetic techniques. Mutat. Res. 1988, 204, 379-406.
45. Kašuba, V.; Rozgaj, R.; Kopjar, N.; Želježić, D.; Jazbec, A. Sister chromatid exchange analysis in peripheral blood lymphocytes of healthy individuals. Biologia (Bratislava) 2002, 57, 401-407.
46. Milković-Kraus, S.; Horvat, T. Chromosomal abnormalities among nurses occupationally exposed to antineoplastic drugs. Am. J. Ind. Med. 1991, 19, 771-774.
47. Brumen, V.; Horvat, T. Work environment influence on cytostatics-induced genotoxicity in oncologic nurses. Am. J. Ind. Med. 1996, 30, 67-71.
48. Fučić, A.; Jazbec, A.; Mijić A.; Šešo-Šimić, D.; Tomek, R. Cytogenetic consequences after occupational exposure to antineoplastic drugs. Mutat. Res. 1998, 416, 59-66.
49. Kašuba, V.; Rozgaj, R.; Garaj-Vrhovac, V. Analysis of sister chromatid exchange and micronuclei in peripheral blood lymphocytes of murses handling cytostatic drugs. J. Appl. Toxicol. 1999, 19, 401-404.
50. Kopjar, N.; Garaj-Vrhovac, V. Application of the alkaline comet assay in human biomonitoring for genotoxicity: a study on Croatian medical personnel handling antineoplastic drugs. Mutagenesis 2001, 16, 71-78.
51. Waksvik, H.; Klepp, O.; Brøgger, A. Chromosome analyses of nurses handling cytostatic agents. Cancer Treat. Repts., 1981, 65, 607-610.
52. Lambert, B.; Bredberg, A.; McKenzie, W.; Sten, M. Sister chromatid exchange in human populations: the effect of smoking, drug treatment and occupational exposure. Cytogenet. Cell Genet. 1982, 33, 62-67.
53. Pohlová, H.; Cerná, M.; Rössner, P. Chromosomal aberrations, SCE and urine mutagenicity in workers occupationally exposed to cytostatic drugs. Mutat. Res. 1986, 174, 213-217.
54. Thiringer, G.; Granung, G.; Holmén, A.; Hogstedt, B.; Jarvhom, B.; Jonsson, D.; Persson, L.; Wahlstrom, J.; Westin, J. Comparison of methods for the biomonitoring of nurses handling antitumor drugs. Scand. J. Work Environ. Health 1991, 17, 133-138.
55. Şardaş, S.; Gök, S.; Karakaya, A.E. Sister chromatid exchanges in lymphocytes of nurses handling antineoplastic drugs. Toxicol. Lett. 1991, 55, 311-315.
56. Goloni-Bertollo, E.M.; Tajara, E.H.; Manzato, A.J.; Varella-Garcia, M. Sister chromatid exchanges and chromosome aberrations in lymphocytes of nurses handling antineoplastic drugs. Int. J. Cancer 1992, 50, 341-344.
57. Karelová, J.; Jablonická, A.; Gavora, J.; Hano, L. Chromosome and sister-chromatid exchange analysis in peripheral lymphocytes and mutagenicity of urine in anesthesiology personnel. Int. Arch. Occup. Environ. Health 1992, 64, 303-306.
58. Roth, S.; Norppa, H.; Järventaus, H.; Kyyrönen, P.; Ahonen, M.; Lehtomäki, J.; Sainio, H.; Sorsa, M. Analysis of chromosomal aberrations, sister chromatid exchanges and micronuclei in peripheral lymphocytes of pharmacists before and after working with cytostatic drugs. Mutat. Res. 1994, 325, 157-162.
59. Kevekordes, S.; Gebel, T.W.; Hellwig, M.; Dames, Dunkelberg, H. Human effect monitoring in cases of occupational exposure to antineoplastic drugs: a method comparison. Occup. Environ. Med. 1998, 55, 145-149.
60. Jakab, M.G.; Major, J.; Tompa, A. Follow-up genotoxicological monitoring of nurses handling antineoplastic drugs. J. Tox. Environ. Health 2001, 62, 307-318.
61. Kolmodin-Hedman, B.; Hartvig, P.; Sorsa, M.; Falck, K. Occupational handling of cytostatic drugs. Arch. Toxicol. 1983, 54, 25-33.
62. Stiller, A.; Obe, G.; Boll, I.; Pribilla, W. No elevation of the frequencies of chromosomal alterations as a consequence of handling cytostatic drugs: Analyses with peripheral blood and urine of hospital personnel. Mutat. Res. 1983, 121, 253-259.
63. Barale, R.; Sozzi, G.; Toniolo, P.; Borghi, O.; Reali, D.; Loprieno, N.; Della Porta, G. Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs. Mutat. Res. 1985, 157, 235-240.
64. Jordan, D.K.; Patil, S.R.; Jochimsen, P.R.; Lachenbruch, P.A.; Corder, M.P. Sister chromatid exchange analysis in nurses handling antineoplastic drugs. Cancer Invest. 1986, 4, 101-107.
65. Stücker, I.; Hirsch, A.; Doloy, T.; Bastie-Sigeac, I.; Hémon, D. Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs. Int. Arch. Occup. Environ. Health 1986, 57, 195-205.
66. Benhamou, S.; Pot-Deprun, J.; Sancho-Garnier, H.; Chouroulinkov, I. Sister chromatid exchanges and chromosomal aberrations in lymphocytes of nurses handling cytostatics agents. Int. J. Cancer 1988, 41, 350-353.
67. Krepinsky, A.; Bryant, D.W.; Davison, L.; Heddle, J.; McCalla, D.R.; Douglas, G.; Michalko, K. Comparison of three assays for genetic effects of antineoplastic drugs on cancer patients and their nurses. Environ. Mol. Mutagen. 1990, 15, 83-92.
68. Oestreicher, U.; Stephan, G.; Glatzel, M. Chromosome and SCE analysis in peripheral lymphocytes of persons occupationally exposed to cytostatic drugs handled with and without use of safety covers. Mutat. Res. 1990, 242, 271-277.
69. Sarto, F.; Trevisan, A.; Tomanin R.; Canova, A.; Fiorentino, M. Chromosomal aberrations, sister chromatid exchanges and urinary thioethers in nurses handling antineoplastic drugs. Am. J. Ind. Med. 1990, 18, 689-695.
70. Ensslin, A.S.; Huber, R.; Pethran, A.; Rommelt, H.; Schierl, R.; Kulka, U.; Fruhmann, G. Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies. Int. Arch. Occup. Environ. Health 1997, 70, 205-208.
71. Lanza, A.; Robustelli della Cuna, F.S.; Zibera, C.; Pedrazzoli, P.; Robustelli della Cuna, G. Somatic mutations at the T-cell antigen receptor in antineoplastic drug-exposed populations: comparison with sister chromatid exchange frequency. Int. Arch. Environ. Health 1999, 72, 315-322.
72. Pilger, A.; Kohler, I.; Stettner, H.; Mader, R.M.; Rizovski, B.; Terkola, R.; Diem, E.; Franz-Hainzl, E.; Konnaris, C.; Valic, E.; Rüdiger, H.W. Long-term monitoring of sister chromatid ecchanges and micronucleus formation in pharmacy personnel occupationally exposed to cytostatic drugs. Int. Arch. Occup. Environ. Health 2000, 73, 442-448.
73. Iijima, K.; Morimoto, K. Cell-stage dependence of mutagen-induced sister-chromatid exchanges in human lymphocyte cultures. Mutat. Res. 1986, 162, 121-129.
74. Aydemir, N.; Çeliker, S.; Bilaloglu, R. In vitro toxic effects of the anticancer drug gemcitabine in human lymphocytes. Mutat. Res. 2005, 582, 35-41.
75. Kopjar, N.; Želježić, D.; Lucić Vrdoljak, A.; Radić B.; Ramić, S.; Milić, M.; Gamulin, M.; Pavlica, V.; Fučić, A. Irinotecan toxicity to human blood cells in vitro-relationships between various biomarkers. Basic Clin. Pharmacol. Toxicol. 2007, 100, 403-413.
76. Bonassi, S.; Forni, A.; Bigatti, P.; Canevarollo, N.; De Ferrari, M.; Lando, C.; Padovani, P.; Bevegni, M.; Stella, M.; Vecchio, D.; Puntoni, R. Chromosome aberrations in hospital workers: evidence from surveillance studies in Italy (1963-1993). Am. J. Ind. Med. 1997, 31, 353-360.
77. Garaj-Vrhovac, V.; Kopjar, N. Investigation into possible DNA damaging effects of ultrasound in occupationally exposed medical personnel - the alkaline comet assay study. J. Appl. Toxicol. 2005, 25, 184-192.
78. Kopjar, N.; Garaj-Vrhovac, V. Assessment of DNA damage in nuclear medicine personnel - comparative study with the alkaline comet assay and the chromosome aberration test. Int. J. Hyg. Environ. Health 2005, 208, 179-191.
79. Nikula, E.; Kiviniitty, K.; Leisti, J.; Taskinen, P.J. Chromosome aberrations in lymphocytes of nurses handling cytostatic agents. Scand. J. Work. Environ. Health, 1984, 10, 71-74.
80. Carbonell, E.; Peris, F.; Xamena, N.; Creus, A.; Marcos, R. SCE analysis in human lymphocytes of a Spanish control population. Mutat. Res. 1995, 335, 35-46.
81. Green, M.H. Influence of environmental and genetic factors on variation in human response to DNA damaging agents. Environ. Toxicol. Pharmacol. 1996, 2, 151-155.
82. Wojewódzka, M.; Kruszewski, M.; Iwanenko, T.; Collins, A.R.; Szumiel, I. Lack of adverse effect of smoking habit on DNA strand breakage and base damage, as revealed by the alkaline comet assay. Mutat. Res. 1999, 440, 19-25.
83. Hirsch B.A.; Sentz, K.K.; McGue, M. Genetic and environmental influences on baseline SCE. Environ. Mol. Mutagen. 1992, 20, 2-11.
84. Lambert, B. Sister chromatid exchange in human lymphocytes as an indicator of DNA damage and repair in vivo. In Lymphocyte stimulation; Castellani, A. Ed.; Plenum Publishing Corporation: New York, 1980; 119-130.
85. Bolognesi, C.; Abbondandolo, A.; Barale, R.; Casalone, R.; Dalprà, L.; De Ferrari, M.; Degrassi, F.; Forni, A.; Lamberti, L.; Lando, C.; Migliore, L.; Padovani, P.; Pasquini, R.; Puntoni, R.; Sbrana, I.; Stella, M.; Bonassi, S. Age-ralated increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations and micronuclei in human lymphocytes. Cancer Epidem. Biom. Prev. 1997, 6, 249-256.
86. Bender, M.A.; Preston, J.; Leonard, R.C.; Pyatt, B.E.; Gooch, P.C.; Shelby, M.D. Chromosomal aberration and sister chromatid exchange frequencies in peripheral lymphocytes of a large human population sample. Mutat. Res. 1988, 204, 421-433.
87. Betti, C.; Davini, T.; Gianessi, L.; Loprieno, N.; Barale, R. Microgel electrophoresis assay (comet test) and SCE analysis in human lymphocytes from 100 normal subjects. Mutat. Res. 1994, 307, 323-333.
88. Sharma, T.; Das, B.C. Higher incidence of spontaneous sister-chromatid exchanges (SCEs) and X-ray-induced chromosome aberrations in peripheral blood lymphocytes during pregnancy. Mutat. Res. 1986, 174, 27-33.
89. Landi, S.; Barale, R. Sister chromatid exchanges, chromosome aberrations and micronuclei in female lymphocytes: correlation with biological rhythms, miscarriages and contraceptive pill use. Mutagenesis 1999, 14, 581-585.
90. Bonassi, S.; Bolognesi, C.; Abbondandolo A.; Barale, R.; Bigatti, P.; Camurri, L.; Dalpra, L.; De Ferrari, M.; Forni, A.; Lando, C.; Padovani, P.; Pasquini, R.; Stella, M.; Puntoni, R. Influence of sex on cytogenetic end points: evidence from a large human sample and a review of the literature. Cancer Epidemiol. Biomarker. Prev. 1995, 4, 671-679.
91. Vijayalaxmi, V.; Evans, H.J. In vivo and in vitro effects of cigarette smoke on chromosomal damage an sister-chromatid exchange in human peripheral blood lymphocytes. Mutat. Res. 1982, 92, 321-332.
92. Livingston, G.K.; Fineman, R.M. Correlation of human lymphocyte SCE frequency with smoking history. Mutat. Res. 1983, 119, 59-64.
93. Reidy, J.A.; Annest, J.L.; Chen, A.T.L.; Welty, T.K. Increased sister chromatid exchange associated with smoking and coffee consumption. Environ. Mol. Mutagen. 1988, 12, 311-318.
94. Tucker, J.D.; Ashworth, L.K.; Johnston, G.R.; Allen, N.A.; Carrano, A.V. Variation in human lymphocyte sister chromatid exchange frequency: results of a long-term longitudinal study. Mutat. Res. 1988, 204, 435-444.
95. Dündaröz, R.; Ulucan H.; Denli, M.; Karapínar, K.; Aydin H.I.; Baltací, V. Evaluation of DNA damage using the comet assay in children on long-term benzathine penicillin for secondary prophylaxix of rheumatic fever. Pediat. Int. 2001, 43, 276-280.
96. Gónzalez, C.; Nájera, O.; Cortés, E.; Toledo, G.; López, L.; Betancourt, M.; Ortiz, R. Susceptibility to DNA damage induced by antibiotics in lymphocytes from malnourished children. Teratogen. Carcinogen. Mutagen. 2002, 22, 147-158.
97. Slapšytė, G.; Jankauskienė, A.; Mieraiskienė, J.; Lazutka, J.R. Cytogenetic analysis of peripheral blood lymphocytes of children treated with nitrofurantion for recurrent urinary tract infection. Mutagenesis 2002, 17, 31-35.
98. López Nigro, M.M.; Palermo, A.M.; Mudry, M.D.; Carballo, M.A. Cytogenetic evaluation of two nitroimidazole derivatives. Toxicol. In Vitro 2003, 17, 35-40.
99. Perry, P.; Evans, H.J. Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange. Nature 1975, 258, 121-125.
100. Morgan, W.F.; Crossen, P.E. X irradiation and sister chromatid exchange in cultured human lymphocytes. Environ. Mol. Mutagen. 2006, 2, 149-155.
101. Gutiérrez, S.; Carbonell, E.; Galofré, P.; Creus, A.; Marcos, R. Low sensitivity of the sister chromatid exchange assay to detect the genotoxic effects of radioiodine therapy. Mutagenesis 1999, 14, 221-226.
102. Ahmad, M.E.; Shadab, G.G.H.A.; Hoda, A.; Afzal, M. Genotoxic effects of estradiol-17β on human lymphocyte chromosomes. Mutat. Res. 2000, 466, 109-115.
103. Kayikçioñlu, F.; Güneû, M.; Baltac , V.; Koçak, M.; Alpas, ē.; Haberal, A. Sister-chromatid exchange frequencies in postmenopausal hormone replacement patients. Mutat. Res. 2000, 452, 37-39.
104. Jacobson-Kram, D. The effects of diagnostic ultrasound on sister chromatid exchange frequencies: a review of the recent literature. J. Clin. Ultrasound 1984, 12, 5-10.
105. Skov, T.; Maarup, B.; Olsen, J.; Rorth, M.; Winterhereik, H.; Lynge, E. Leukemia and reproductive outcome among nurses handling antineoplastic drugs. Brit. J. Ind. Med. 1992, 49, 855-861.
106. Gunnarsdottir, H.K.; Aspelund, T.; Karlsson, T.; Rafnsson, V. Occupational risk factors for breast cancer among nurses. Int. J. Occup. Environ. Health 1997, 3, 254-258.
107. Levin, L.I.; Holly, E.A.; Seward, J.P. Bladder cancer in a 39-year-old female pharmacist. J. Natl. Cancer Inst. 1993, 85, 1089-1090.
108. Gabriele. P.; Airoldi, M.; Succo, G.; Brando, V.; Ruo Redda, M.G. Undifferentiated nasopharyngeal-type carcinoma in a nurse handling cytostatic agents. Oral Oncol. Eur. J. Cancer 1993, 29B, 153.
109. Hagmar, L.; Bonassi, S.; Strömberg, U.; Mikoczy, Z.; Lando, C.; Hansten, I.-L.; Huici Montagud, A.; Knudsen, L.; Norppa, H.; Reuterwall, C.; Tinnerberg, H.; Brøgger, A.; Forni, A.; Högstedt, B.; Lambert, B.; Mitelman, F.; Nordenson, I.; Salomaa, S.; Skerfving, S. Cancer predictive value of cytogenetic markers used in occupational health surrveilance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. Mutat. Res. 1998, 405, 171-178.
110. Norppa, H.; Bonassi, S.; Hansten I.-L.; Hagmar, L.; Strömberg, U.; Rössner, P.; Boffetta, P.; Lindholm, C.; Gundy, S.; Lazutka, J.; Cebulska-Wasilewsk, A.; Fabiánová, E.; Šrám, R.J.; Knudsen, L.E.; Barale, R.; Fučić, A. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat. Res. 2006, 600, 37-45.
111. Tucker, J.D.; Preston, R.J. Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment. Mutat. Res. 1996, 365, 147-159.
112. Fenech, M. Chromosomal biomarkers of genomic instability relavant to cancer. DDT. 2002, 7, 1128-1137.
113. Digue, L.; Orsiere, T.; De Meo, M.; Mattei, M.G.; Depetris, D.; Duffaud, F.; Favre, R.; Botta, A. Evaluation of the genotoxic activity of paclitaxel by the in vitro micronucleus test in combination with fluorescent in situ hybridization of a DNA centromeric probe and the alkaline single cell gel electrophoresis technique (comet assay) in human T-lymphocytes. Environ. Mol. Mutagen. 1999, 34, 269-278.
114. Pavlica, V. The assessment of risks caused by occupational exposure to cytotoxic drugs. (PhD thesis). Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, 2007; 246pp.
115. Connor, T.H.; Anderson, R.W.; Sessink, P.J.; Broadfield, L.; Power, L.A. Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and United States. Am. J. Health-Syst. Pharm. 1999, 56, 1427-1432.
116. Fransman, W.; Vermuelen, R.; Kromhout, H. Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study. Ann. Occup. Hyg. 2004, 48, 237-244.
117. Crauste-Manciet, S.; Sessink, P.J.M.; Ferrari, S.; Jomier. J.-Y.; Brossard, D. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Ann. Occup. Hyg. 2005, 49, 619-628.